ArticleApplied health economics and health policy2021
Willingness to Pay for a COVID-19 Vaccine.
Article in Applied health economics and health policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
75 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Prevalence of caregiver hesitancy for vaccinations in children and its associated factors: A systematic review and meta-analysis.PloS one · 2024Pooled it
- Implications for COVID-19 vaccine uptake: A systematic review.Journal of infection and public health · 2023Pooled it
- Determinants of willingness to pay for health services: a systematic review of contingent valuation studies.The European journal of health economics : HEPAC : health economics in prevention and care · 2022Pooled it
- Nudges for COVID-19 voluntary vaccination: How to explain peer information?Social science & medicine (1982) · 2022Trial
- Do Patients Value the Service Provided by Physicians Who Overbill? A Willingness-to-Pay Study Using French Survey Data.Health economics · 2026Article
- Association Between Socio-Political and Economic Factors and COVID-19 Vaccination Uptake: US-Mexico Border Study.Epidemiologia (Basel, Switzerland) · 2026Article
- Effect of a pharmacist-led infodemic management intervention on perception, willingness to receive and pay for adult vaccines among civil servants in Akwa Ibom State, Nigeria.BMC infectious diseases · 2026Article
- Transition from Free to Paid Vaccination: Willingness to Pay for COVID-19 Booster Doses in Vietnam in the Post-Pandemic Era.ClinicoEconomics and outcomes research : CEOR · 2026Article
- Factors influencing the COVID-19 vaccine uptake among Ukrainian refugees in Poland: a cross-sectional study.Frontiers in public health · 2026Article
- Willingness to pay for digital care for NCD in Ghana: an exploratory study of three health facilities in Ghana.BMC health services research · 2025Article
- Drivers of COVID-19 infections: Perspectives of managers in the Gauteng Department of Health, South Africa.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2025Article
- Disparity between expected spatial accessibility and actual travel time to vaccination sites: Implications for COVID-19 immunization delays.SSM - population health · 2025Article
- The present value of human life losses associated with COVID-19 and likely productivity losses averted through COVID-19 vaccination in Madagascar.BMC public health · 2024Article
- Letter to the editor: willingnessPublic health nutrition · 2024Article
- The acceptability of the risk of death in the treatment of respiratory diseases in France.Health economics review · 2024Review
- Individuals' willingness to pay for HIV vaccines in Iran: Contingent valuation method.Health science reports · 2024Article
- The Value of Flexible Vaccine Manufacturing Capacity: Value Drivers, Estimation Methods, and Approaches to Value Recognition in Health Technology Assessment.PharmacoEconomics · 2024Review
- Public Preference for Financing Preventive Vaccines in Health Shocks: The Case of COVID-19 Vaccines in a Middle-Income Country.PharmacoEconomics - open · 2024Article
- Sociodemographic determinants of vaccination and willingness to pay for COVID-19 vaccines in Hungary, results of a cross-sectional online questionnaire.BMC public health · 2024Article
- Determinants of vaccination decisions and lived experiences of Ghanaians with the COVID-19 pandemic; a qualitative study.Vaccine: X · 2024Article
15 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe coronavirus disease (COVID-19) pandemic has considerably affected the lives of people worldwide, impacting their health and economic welfare, and changing the behavior of our society significantly. This situation may lead to a strong incentive for people to buy a vaccine. Therefore, a relevant study to assess individuals' choices and the value of change in welfare from a COVID-19 vaccine is essential.
objectiveThis study aimed to estimate the willingness-to-pay (WTP) value for a vaccine for COVID-19. We also identify the variables that influence individual vaccination decisions, which could be used in the design of vaccination promotion strategies.
methodsWe use the contingent valuation method in its double-bounded dichotomous choice format. The estimation coefficients are calculated according to the maximum likelihood method under the assumption of a probit distribution. The sample consisted of 531 individuals, mainly from middle- and high-income socioeconomic groups from Chile between enrolled between 10 July and 10 August 2020.
resultsThe results show a high WTP for the COVID-19 vaccine, with a value up to US$232. Income and education levels and having family members with COVID-19 increased the likelihood of persons paying for a vaccine. There is also a greater fear as the pandemic progresses that people will get sick from COVID-19.
conclusionsThe high WTP value creates an opportunity for formulating public health policy. The results of this study suggest that governments can provide the vaccine free to low-income groups and allow those with higher incomes to acquire the vaccine through the private sector by paying. This will be useful especially for countries with economic difficulties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.